SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

EyePoint Reports Third Quarter 2026 Financial Results and Provides Recent Corporate Developments

Organizational focus on DURAVYUTM Phase 3 DME program; trials fully enrolled with topline data exp

EYPT

Related stories